These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 8995964)
1. Trimethoprim-sulfamethoxazole-induced vanishing bile duct syndrome. Yao F; Behling CA; Saab S; Li S; Hart M; Lyche KD Am J Gastroenterol; 1997 Jan; 92(1):167-9. PubMed ID: 8995964 [No Abstract] [Full Text] [Related]
2. Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) after administration of clindamycin and trimethoprim-sulfamethoxazole. Altraif I; Lilly L; Wanless IR; Heathcote J Am J Gastroenterol; 1994 Aug; 89(8):1230-4. PubMed ID: 8053440 [TBL] [Abstract][Full Text] [Related]
3. Intrahepatic cholestasis associated with co-trimoxazole. Oliver RM; Rickenbach MA; Thomas MR; Neville E Br J Clin Pract; 1987 Oct; 41(10):975-6. PubMed ID: 3509795 [No Abstract] [Full Text] [Related]
4. Vanishing bile duct syndrome arising in a patient with HIV infection sequentially treated with trimethoprim/sulfamethoxazole and dapsone. Kathi PR; Tama M; Ehrinpreis M; Mutchnick M; Westerhoff M; Mowers J; Fontana RJ Clin J Gastroenterol; 2020 Apr; 13(2):276-280. PubMed ID: 31317370 [TBL] [Abstract][Full Text] [Related]
5. Trimethoprim-sulfamethoxazole-associated hepatotoxicity - part of a hypersensitivity syndrome. Mainra RR; Card SE Can J Clin Pharmacol; 2003; 10(4):175-8. PubMed ID: 14712321 [TBL] [Abstract][Full Text] [Related]
7. Vanishing bile duct syndrome in a child with toxic epidermal necrolysis: an interplay of unbalanced immune regulatory mechanisms. Karnsakul W; Arkachaisri T; Atisook K; Wisuthsarewong W; Sattawatthamrong Y; Aanpreung P Ann Hepatol; 2006; 5(2):116-9. PubMed ID: 16807519 [TBL] [Abstract][Full Text] [Related]
8. Restoration of bile ducts in drug-induced vanishing bile duct syndrome due to zonisamide. Vuppalanchi R; Chalasani N; Saxena R Am J Surg Pathol; 2006 Dec; 30(12):1619-23. PubMed ID: 17122520 [TBL] [Abstract][Full Text] [Related]
16. A first case of trimethoprim-sulfamethoxazole induced Sweet's syndrome in a child. Khaled A; Kharfi M; Fazaa B; Kourda M; Bouaziz A; Kastalli S; Kamoun MR Pediatr Dermatol; 2009; 26(6):744-6. PubMed ID: 20199454 [No Abstract] [Full Text] [Related]
17. Hydroxycut-related Vanishing Bile Duct Syndrome. Adike A; Smith ML; Chervenak A; Vargas HE Clin Gastroenterol Hepatol; 2017 Jan; 15(1):142-144. PubMed ID: 27151488 [No Abstract] [Full Text] [Related]
18. [Tremor produced by trimethoprim-sulfamethoxazole]. de Arce Borda AM; Goenaga Sánchez MA Neurologia; 2000; 15(6):264-5. PubMed ID: 11002706 [No Abstract] [Full Text] [Related]
19. Vanishing bile duct syndrome temporally associated with ibuprofen use. Alam I; Ferrell LD; Bass NM Am J Gastroenterol; 1996 Aug; 91(8):1626-30. PubMed ID: 8759674 [TBL] [Abstract][Full Text] [Related]
20. [Prolonged cholestasis following single dose of cotrimoxazole++]. Ruiz-Irastorza G; Montejo M; Ituarte J; Aguirre C Rev Clin Esp; 1996 Dec; 196(12):879-80. PubMed ID: 9132870 [No Abstract] [Full Text] [Related] [Next] [New Search]